{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,17]],"date-time":"2025-10-17T20:07:05Z","timestamp":1760731625900,"version":"3.41.2"},"reference-count":25,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T00:00:00Z","timestamp":1705276800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Med."],"abstract":"<jats:sec><jats:title>Purpose<\/jats:title><jats:p>Retinal angiopathy represents a well-known ocular manifestation of hereditary transthyretin amyloidosis (ATTRv). Until recently, there have been no reports on retinal changes in ATTRwt. In this retrospective observational clinical study, we aimed to determine whether vessel density (VD) indices and the choroidal vascularity index (CVI) could offer insights into retinal and choroidal vascular changes among patients affected by ATTRwt.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Eighteen patients with a confirmed diagnosis of ATTRwt underwent structural optical coherence tomography (OCT) and OCT angiography (OCTA). We established a control group consisting of 16 healthy subjects for statistical comparisons. The 3D OCT and OCTA datasets were analyzed to assess retinal and choroidal thickness and VD. For measuring CVI, we obtained measurements for the total choroid area (TCA), luminal area (LA), and stromal area (SA).<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>The mean VD exhibited a statistically significant reduction in the superficial capillary plexus (SCP), deep capillary plexus (DCP), and choriocapillaris (CC) among the ATTRwt group in comparison to the control group (<jats:italic>p<\/jats:italic> &amp;lt; 0.0001). Notably, ATTRwt patients displayed decreased choroidal thickness (<jats:italic>p<\/jats:italic> = 0.08). Additionally, the median CVI was lower in the ATTRwt group than in the control group (<jats:italic>p<\/jats:italic> = 0.04).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>The indices from OCTA and CVI have the potential to serve as non-invasive biomarkers for the quantitative evaluation of retinal and choroidal vascular involvement in patients with ATTRwt.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fmed.2023.1174643","type":"journal-article","created":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T13:53:55Z","timestamp":1705326835000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":3,"title":["OCT angiography indices and the choroidal vascularity index in wild-type transthyretin (TTR) amyloidosis (ATTRwt)"],"prefix":"10.3389","volume":"10","author":[{"given":"Michele","family":"Rinaldi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fausto","family":"Tranfa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flavia","family":"Chiosi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Campagna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maddalena","family":"De Bernardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Gioia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Natale","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Caiazza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Dongiglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Federica","family":"Verrillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Palmiero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giuseppe","family":"Limongelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ciro","family":"Costagliola","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2024,1,15]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1016\/S0140-673601274-X","article-title":"Systemic amyloidosis","volume":"387","author":"Wechalekar","year":"2016","journal-title":"Lancet."},{"key":"B2","doi-asserted-by":"publisher","first-page":"73","DOI":"10.1016\/j.hfc.2021.07.006","article-title":"Cardiovascular involvement in transthyretin cardiac amyloidosis","volume":"18","author":"Lioncino","year":"2022","journal-title":"Heart Fail Clin."},{"key":"B3","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1136\/jnnp-2014-308724","article-title":"Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments","volume":"86","author":"Sekijima","year":"2015","journal-title":"J Neurol Neurosurg Psychiatry."},{"key":"B4","doi-asserted-by":"publisher","first-page":"105313","DOI":"10.1016\/j.neuint.2022.105313","article-title":"Transthyretin: its function and amyloid formation","volume":"155","author":"Ueda","year":"2022","journal-title":"Neurochem Int."},{"key":"B5","doi-asserted-by":"publisher","first-page":"775","DOI":"10.1097\/IAE.0000000000003378","article-title":"Choroidal involvement in hereditary transthyretin amyloidosis patients","volume":"42","author":"Marta","year":"2022","journal-title":"Retina."},{"key":"B6","doi-asserted-by":"publisher","first-page":"407","DOI":"10.1080\/13816810.2019.1666413","article-title":"Multimodal retinal imaging of familial amyloid polyneuropathy","volume":"40","author":"Latasiewicz","year":"2019","journal-title":"Ophthalmic Genet."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1037","DOI":"10.1097\/IAE.0000000000002961","article-title":"Association between choroidal characteristics and systemic severity in amyloidosis","volume":"41","author":"Mano","year":"2021","journal-title":"Retina."},{"key":"B8","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1097\/IAE.0000000000003291","article-title":"Ocular angiographic features in Japanese patients with val30met hereditary transthyretin amyloidosis","volume":"42","author":"Kakihara","year":"2022","journal-title":"Retina."},{"key":"B9","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1097\/IAE.0000000000003641","article-title":"Ophthalmologic involvement in patients with hereditary transthyretin amyloidosis","volume":"43","author":"Ruiz-Medrano","year":"2023","journal-title":"Retina."},{"key":"B10","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1080\/13506129.2020.1827381","article-title":"Subclinical retinal angiopathy associated with hereditary transthyretin amyloidosis - assessed with optical coherence tomography angiography","volume":"28","author":"Marques","year":"2021","journal-title":"Amyloid."},{"key":"B11","doi-asserted-by":"publisher","first-page":"2227","DOI":"10.2147\/OPTH.S359312","article-title":"Monitoring the patient with retinal angiopathy associated with hereditary transthyretin amyloidosis: current perspectives","volume":"16","author":"Marques","year":"2022","journal-title":"Clin Ophthalmol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"21090","DOI":"10.1038\/srep21090","article-title":"Choroidal vascularity index as a measure of vascular status of the choroid: measurements in healthy eyes from a population-based study","volume":"6","author":"Agrawal","year":"2016","journal-title":"Sci Rep"},{"key":"B13","doi-asserted-by":"publisher","first-page":"1123","DOI":"10.1016\/j.ajo.2015.03.005","article-title":"Luminal and stromal areas of choroid determined by binarization method of optical coherence tomographic images","volume":"159","author":"Sonoda","year":"2015","journal-title":"Am J Ophthalmol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1002\/(SICI)1521-403642:1<17::AID-BIMJ17>3.0.CO;2-U","article-title":"Munzel U. The nonparametric Behrens-Fisher problem: asymptotic theory and a small-sample approximation","volume":"42","author":"Brunner","year":"2000","journal-title":"Biom J"},{"key":"B15","doi-asserted-by":"publisher","first-page":"1081","DOI":"10.1162\/jocn.2007.19.7.1081","article-title":"Improving lesion-symptom mapping","volume":"19","author":"Rorden","year":"2007","journal-title":"J Cogn Neurosci."},{"key":"B16","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s00265-0080683-4","article-title":"Distribution-free two-sample comparisons in the case of heterogeneous variances","volume":"63","author":"Neuh\u00e4user","year":"2009","journal-title":"Behav Ecol Sociobiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1016\/j.jclinepi.2009.08.026","article-title":"A nonparametric two-sample comparison for skewed data with unequal variances","volume":"63","author":"Neuh\u00e4user","year":"2010","journal-title":"J Clin Epidemiol."},{"key":"B18","doi-asserted-by":"publisher","first-page":"117","DOI":"10.3109\/13506129.2015.1015678","article-title":"Ophthalmological manifestations in hereditary transthyretin (ATTR V30M) carriers: a review of 513 cases","volume":"22","author":"Beir\u00e3o","year":"2015","journal-title":"Amyloid."},{"key":"B19","doi-asserted-by":"publisher","first-page":"2212","DOI":"10.1016\/j.ophtha.2005.05.028","article-title":"Ocular amyloid angiopathy associated with familial amyloidotic polyneuropathy caused by amyloidogenic transthyretin Y114C","volume":"112","author":"Kawaji","year":"2005","journal-title":"Ophthalmology."},{"key":"B20","doi-asserted-by":"publisher","first-page":"12589","DOI":"10.1111\/jns.12589","article-title":"Ophthalmological involvement in wild-type transthyretin amyloidosis: a multimodal imaging study","volume":"2023","author":"Frizziero","year":"2023","journal-title":"J Peripher Nerv Syst."},{"key":"B21","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1016\/j.jsha.2015.09.003","article-title":"Arterial stiffness and function in transthyretin-related cardiac amyloidosis","volume":"28","author":"Zaghlool","year":"2016","journal-title":"J Saudi Heart Assoc."},{"key":"B22","doi-asserted-by":"publisher","first-page":"e008193","DOI":"10.1161\/CIRCHEARTFAILURE.120.008193","article-title":"Long-term survival with tafamidis in patients with transthyretin amyloid cardiomyopathy","volume":"15","author":"Elliott","year":"2022","journal-title":"Circ Heart Fail."},{"key":"B23","doi-asserted-by":"publisher","first-page":"127","DOI":"10.1007\/s40259-023-00577-7","article-title":"RNA targeting and gene editing strategies for transthyretin amyloidosis","volume":"37","author":"Ioannou","year":"2023","journal-title":"BioDrugs."},{"key":"B24","doi-asserted-by":"publisher","first-page":"8936","DOI":"10.1038\/s41598-021-88250-3","article-title":"Intraocular pressure and choroidal thickness postural changes in multiple system atrophy and Parkinson's disease","volume":"11","author":"De Bernardo","year":"2021","journal-title":"Sci Rep."},{"key":"B25","doi-asserted-by":"publisher","first-page":"16398","DOI":"10.1038\/s41598-021-95812-y","article-title":"Choroidal structural evaluation in celiac disease","volume":"11","author":"De Bernardo","year":"2021","journal-title":"Sci Rep."}],"container-title":["Frontiers in Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1174643\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,1,15]],"date-time":"2024-01-15T13:54:03Z","timestamp":1705326843000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fmed.2023.1174643\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,15]]},"references-count":25,"alternative-id":["10.3389\/fmed.2023.1174643"],"URL":"https:\/\/doi.org\/10.3389\/fmed.2023.1174643","relation":{},"ISSN":["2296-858X"],"issn-type":[{"type":"electronic","value":"2296-858X"}],"subject":[],"published":{"date-parts":[[2024,1,15]]},"article-number":"1174643"}}